Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
Pros and cons of weight-loss jabs
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
Yahoo Finance5d
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Wegovy, to shame. Let's look deeper into these results and what they could mean for investors. Novo Nordisk's weight loss candidate in question is called amycretin. The company is developing an ...
Rolling Out6d
The dark side of weight loss drugs no one warns about
Weight loss drugs have surged in popularity, with millions turning to medications like Ozempic and Wegovy in hopes of ... patients experience transformative results, others face side effects ...